Lennox (LII) Tops Q1 EPS by 17c; offers guidance

Lennox (NYSE: LII) reported Q1 EPS of $3.37, $0.17 better than the analyst estimate of $3.20. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.01 billion.

GUIDANCE:

Lennox sees FY2025 EPS of $22.25-$23.50, versus the consensus of $22.94.

Revenue is still anticipated to increase by approximately 2%. We now expect additional pricing gains to overcome tariffs while preserving profit margins and offsetting the impact of potential volume declines.

Capital expenditures are still projected to be approximately $150 million, and the Free Cash Flow range remains at $650 million to $800 million.

For earnings history and earnings-related data on Lennox (LII) click here.

You May Also Be Interested In

• Phibro Animal Health (PAHC) Tops Q4 EPS by 13c; Offers Guidance
• Ooma (OOMA) Tops Q2 EPS by 2c; offers guidance
• Synopsys (SNPS) Tops Q3 EPS by 24c; offers guidance